TickerFacts.

Avenue Therapeutics, Inc. (ATXI): Revenue

Annual figures by period end, from SEC filings.

$1.40M
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
2024-12-31: $02025-12-31: $1.40M$1.40M
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.40Mn/a2026-03-30, From 2025-01-01
2024-12-31$0n/a2026-03-30, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Avenue Therapeutics, Inc. (ATXI)2025-12-31$1.40Mn/a
Northwest Biotherapeutics Inc (NWBO)2025-12-31$1.38M-0.3%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$1.45Mn/a
Cannapharmarx, Inc. (CPMD)2025-12-31$1.36M+66.1%
IGC Pharma, Inc. (IGC)2025-03-31$1.27M-5.5%
Vistagen Therapeutics, Inc. (VTGN)2026-03-31$1.27M+161.1%
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31$1.63M+58.9%
Longeveron Inc. (LGVN)2025-12-31$1.20M-49.9%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$1.17M-92.5%

Compare ATXI, NWBO, NRXP, CPMD side by side · Screen every company in Pharmaceutical Preparations ↗